abstract |
The present invention relates to the use of a mixture comprising at least a lipopeptide for the production of a vaccine. The lipopeptide comprises a peptide compound linked in solution by hydrazone linkage to at least one non-peptide lipophilic vector. The invention also relates to the native sequence NS3 of HCV. |